24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Immune-Oncology
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
14:26
The content collapse: How AI broke the internet’s oldest business model
14:02
Pango reboots Gett deal with Leumi Partners and decentralized investor group
13:00
Cyera doubles valuation to $6 billion with $540M Series E
10:12
Who inherits your cloud? Preparing for digital legacy in the age of data
More stories
Buzz
Most popular
Daily
Weekly
1
Andreessen Horowitz targets elite IDF alumni for startup accelerator
2
Cyera doubles valuation to $6 billion with $540M Series E
3
Tastewise raises $50M to power the AI brain behind Kraft, Mars, and Campbell’s
4
eToro’s Wall Street honeymoon ends abruptly after first earnings call
5
Vast Data eyes $25 billion valuation amid AI boom
More news
Immune-Oncology
1 stories about Immune-Oncology
AstraZeneca Signs Deal with Cancer Immunotherapy Company Compugen
03.04.18
|
Lilach Baumer
The deal has the potential to be worth over $200 million for Nasdaq-listed Compugen